Bruno Wohlschlegel - Net Worth and Insider Trading
Bruno Wohlschlegel Net Worth
The estimated net worth of Bruno Wohlschlegel is at least $0 dollars as of 2024-11-09. Bruno Wohlschlegel is the Board of Directors of Apontis Pharma AG and owns about 0 shares of Apontis Pharma AG (XTER:APPH) stock worth over $0. Details can be seen in Bruno Wohlschlegel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bruno Wohlschlegel has not made any transactions after 2024-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bruno Wohlschlegel
Bruno Wohlschlegel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bruno Wohlschlegel owns 1 companies in total, including Apontis Pharma AG (XTER:APPH) .
Click here to see the complete history of Bruno Wohlschlegel’s form 4 insider trades.
Insider Ownership Summary of Bruno Wohlschlegel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XTER:APPH | Apontis Pharma AG | 2024-05-13 | Board of Directors |
Bruno Wohlschlegel Latest Holdings Summary
Bruno Wohlschlegel currently owns a total of 1 stock. Bruno Wohlschlegel owns 0 shares of Apontis Pharma AG (XTER:APPH) as of May 13, 2024, with a value of $0.
Latest Holdings of Bruno Wohlschlegel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XTER:APPH | Apontis Pharma AG | 2024-05-13 | 0 | 9.76 | 0 |
Holding Weightings of Bruno Wohlschlegel
Bruno Wohlschlegel Form 4 Trading Tracker
According to the SEC Form 4 filings, Bruno Wohlschlegel has made a total of 1 transactions in Apontis Pharma AG (XTER:APPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Apontis Pharma AG is the acquisition of 1,000 shares on May 13, 2024, which cost Bruno Wohlschlegel around $8,880.
Insider Trading History of Bruno Wohlschlegel
- 1
Bruno Wohlschlegel Trading Performance
GuruFocus tracks the stock performance after each of Bruno Wohlschlegel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruno Wohlschlegel is -10.7%. GuruFocus also compares Bruno Wohlschlegel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruno Wohlschlegel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bruno Wohlschlegel's insider trading performs compared to the benchmark.
Performance of Bruno Wohlschlegel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.4 |  | | | | |
| Relative Return to S&P 500(%) | -5.47 | | | | | |
Bruno Wohlschlegel Ownership Network
Ownership Network List of Bruno Wohlschlegel
Ownership Network Relation of Bruno Wohlschlegel
Bruno Wohlschlegel Owned Company Details
What does Apontis Pharma AG do?
Who are the key executives at Apontis Pharma AG?
Bruno Wohlschlegel is the Board of Directors of Apontis Pharma AG. Other key executives at Apontis Pharma AG include Board of Directors Thomas Milz , Chief Financial Officer Thomas Zimmermann , and Board of Directors Karlheinz Gast .
Apontis Pharma AG (XTER:APPH) Insider Trades Summary
Over the past 18 months, Bruno Wohlschlegel made 1 insider transaction in Apontis Pharma AG (XTER:APPH) with a net purchase of 1,000. Other recent insider transactions involving Apontis Pharma AG (XTER:APPH) include a net purchase of 2,200 shares made by Thomas Zimmermann , a net purchase of 1,000 shares made by Thomas Milz ,
In summary, during the past 3 months, insiders sold 0 shares of Apontis Pharma AG (XTER:APPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apontis Pharma AG (XTER:APPH) were sold and 4,200 shares were bought by its insiders, resulting in a net purchase of 4,200 shares.
Apontis Pharma AG (XTER:APPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apontis Pharma AG Insider Transactions
Bruno Wohlschlegel Mailing Address
Above is the net worth, insider trading, and ownership report for Bruno Wohlschlegel. Currently GuruFocus does not have mailing address information for Bruno Wohlschlegel.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
